Trials / Completed
CompletedNCT02305355
Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Kuhnil Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Assess efficacy and safety of Omacor® 4g with statin treatment for lowering TG levels in subjects with type 2 Diabetes combined with hyperlipidemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omega-3-acids ethylesters 90 4g | |
| DRUG | Pravastatin, Simvastatin, Atorvastatin, Rosuvastatin |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2014-12-02
- Last updated
- 2014-12-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02305355. Inclusion in this directory is not an endorsement.